Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Launched by UNIVERSITY OF OXFORD · Jan 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy study is looking to understand why young adults who were born to mothers with high blood pressure during pregnancy might have a higher risk of developing high blood pressure and heart-related diseases later in life. Researchers want to gather more information to help improve health outcomes for these individuals.
To participate in this study, you should be between 30 and 40 years old and have previously taken part in the ALSPAC study. You must also be able to understand English and give your consent to join. If you are currently pregnant, breastfeeding, or have certain health conditions, you may not be eligible. Participants can expect to undergo a variety of assessments to help researchers gather important data about their cardiovascular health. This study is currently recruiting participants, and your involvement could contribute to valuable insights into heart health for young adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the study
- • Male or female, aged 30 to 40 years at time of enrolment
- • Participant previously took part in the ALSPAC study
- • Able (in the investigator's opinion) and willing to comply with all study requirements
- • Adequate understanding of verbal and written English
- Exclusion Criteria:
- • Pregnant or lactating when they are due to attend for study visit 1
- • Less than six months postpartum
- • Planning to donate blood within two weeks prior to study visit 1
- • Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study
- • Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status
- For exclusion of MRI component only:
- • Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, Oxfordshire, United Kingdom
Patients applied
Trial Officials
Adam J Lewandowski
Principal Investigator
Cardiovascular Clinical Research Facility
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials